Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C.

Neurology. 1989 Sep;39(9):1159-65.

PMID:
2771064
2.

Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries.

Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, Lee KH, Kim SY, Han SH, Woo JI.

J Gerontol B Psychol Sci Soc Sci. 2002 Jan;57(1):P47-53.

PMID:
11773223
3.
4.

Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings.

Fillenbaum GG, Beekly D, Edland SD, Hughes JP, Heyman A, van Belle G.

Top Health Inf Manage. 1997 Aug;18(1):47-58.

PMID:
10173753
5.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A.

Neurology. 1994 Apr;44(4):609-14.

PMID:
8164812
6.

The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.

Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G, Heyman A.

Neurology. 1993 Dec;43(12):2457-65.

PMID:
8255439
7.

The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.

Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, Morris JC, Fillenbaum GG, Heyman A.

Neurology. 1997 Jul;49(1):70-5.

PMID:
9222172
8.

Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

Welsh K, Butters N, Hughes J, Mohs R, Heyman A.

Arch Neurol. 1991 Mar;48(3):278-81.

PMID:
2001185
9.
10.

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF.

Neurology. 1998 Jul;51(1):159-62. Erratum in: Neurology 1998 Dec;51(6):1809.

PMID:
9674796
14.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
15.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L.

Neurology. 1991 Apr;41(4):479-86.

PMID:
2011243
16.

CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.

Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M.

Acta Neurol Scand. 2005 Mar;111(3):172-9.

PMID:
15691286
18.
20.

Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?

Zehnder AE, Bläsi S, Berres M, Spiegel R, Monsch AU.

Am J Alzheimers Dis Other Demen. 2007 Oct-Nov;22(5):416-26.

PMID:
17959877
Items per page

Supplemental Content

Write to the Help Desk